Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
This study is ongoing, but not recruiting participants.
Sponsor:
Texas Heart Institute
Collaborators:
St. Luke's Episcopal Hospital, Texas
Aldagen
Information provided by (Responsible Party):
Emerson Perin, MD, PhD, Texas Heart Institute
ClinicalTrials.gov Identifier:
NCT00314366
First received: April 10, 2006
Last updated: December 20, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2021 |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |